| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.4 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |